• Monday, Sep 27, 2021
  • Last Update : 06:57 pm

Russia says India to produce 100m doses of Sputnik vaccine

  • Published at 02:59 pm November 27th, 2020
Sputnik-V Covid-19 vaccine
File photo: A nurse prepares Russia's ‘Sputnik-V’ vaccine against the Covid-19 for inoculation in a post-registration trials stage at a clinic, in Moscow on September 17, 2020 Reuters

Russia said interim results from the Sputnik V clinical trails showed the vaccine was 95% effective

One of the developers of Russia's Sputnik V coronavirus vaccine announced Friday that India-based drugmaker Hetero will produce over 100 million doses of the jab.

"Hetero, one of India's leading generic pharmaceutical companies, have agreed to produce in India over 100 million doses per year of the world's first registered vaccine against the novel coronavirus infection -– Sputnik V," the Russian Direct Investment Fund (RDIF) said in a statement, adding that production was expected to start in early 2021.

Earlier this week, Russia said interim results from the Sputnik V clinical trails showed the vaccine was 95% effective, similar to other international vaccine makers that have also published test results showing efficacy rates of 90% and higher.

Russia also announced that the Sputnik V vaccine will be priced at $10 per dose on international markets, costing less than some other registered Covid-19 vaccines.

Russia was the first country to announce the registration of a coronavirus vaccine in August -- dubbed Sputnik V after the Soviet-era satellite -- but did so ahead of large scale clinical trials.

Currently the third and final phase of trials is underway, with some 40,000 volunteers involved in blind testing of the vaccine that uses two different human adenovirus vectors.

According to Friday's statement, their use "allows for a stronger and longer-term immune response" compared to vaccines that use the same vector in both its doses.

Third phase trials are also underway in the ex-Soviet republic of Belarus, the UAE and Venezuela among other countries.

Apart from India, the RDIF says Sputnik V will also be produced in Brazil, China and South Korea.

"I am confident that Sputnik V should become an integral part of the national vaccine portfolio of every country willing to protect its population from the coronavirus," RDIF head Kirill Dmitriyev was quoted as saying in Friday's statement.

 

52
Facebook 51
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail